Buyer for infectious disease CRO in Europe

Company to buy

• Size: Small to medium-sized business
• Sales: 10 – 30 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business in Europe
• #CFIE PHB245

Overview of buyer for infectious disease CRO in Europe

Currently, this contract research organization (CRO) seeks a strategic acquisition in infectious disease research. Primarily, the company is a leading provider of cutting-edge expertise in epidemiology and pharmacovigilance. In particular, they are dedicated to improving healthcare through data-driven insights and innovative research. Founded about 10 years ago, the company has established itself as a trusted partner for pharmaceutical companies, healthcare organizations, and regulatory agencies around the world.

Profile (strategy) of buyer for infectious disease CRO in Europe

Essentially, the company’s story is one of passion and dedication to healthcare. For instance, the company was founded by a team of experienced professionals with a shared vision to leverage data and scientific expertise to make a real difference in people’s lives. From the outset, the company has been committed to providing its clients with the highest quality services, delivered with integrity and a deep understanding of the healthcare landscape.

Altogether, the company offers a comprehensive range of services, spanning the entire spectrum of drug development and post-marketing surveillance. Their core areas of expertise include:

• Clinical studies
• Epidemiology and RWE
• Medical writing
• Pharmacovigilance
• Qualitative research
• Statistics/IT

Overall, the company has a global presence, with offices in Europe, Latin America, and Asia. Thus, this allows the company to serve clients around the world and to leverage its expertise to address the diverse needs of different healthcare systems. At this time, the company is actively involved in various initiatives to improve global health. For example, supporting clinical research in developing countries and collaborating with academic institutions to advance scientific knowledge.

Activities and products of suitable targets

Now, the buyer is seeking CROs in the field of infectious disease research. Chiefly, the buyer is actively seeking a strategic acquisition in the infectious diseases area to become a leader in full-service infectious disease CRO.

Highlights

• Offers a full spectrum of services encompassing clinical studies, real-world evidence research, medical writing, pharmacovigilance, qualitative research, and data analysis
• Experienced medical writers can create high-quality regulatory documents, clinical reports, and scientific publications
• Proven track record in successfully designing and executing clinical trials of all sizes and complexities across various therapeutic areas
• Renowned RWE expertise leveraging advanced data analysis techniques to provide actionable insights on medication performance in real-world settings
• Global presence, with offices in Europe, Latin America, and Asia

More information on this buyer for infectious disease CRO in Europe

Please get in touch if you are interested in learning more about this buyer for infectious disease CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.